Myovant Sciences Performance
| MYOVDelisted Stock | USD 26.98 0.01 0.04% |
The company secures a Beta (Market Risk) of 0.0366, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Myovant Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Myovant Sciences is expected to be smaller as well. Myovant Sciences right now secures a risk of 0.0%. Please verify Myovant Sciences value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Myovant Sciences will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Myovant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Myovant Sciences is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 677.5 M | |
| Total Cashflows From Investing Activities | -18 M |
Myovant |
Myovant Sciences Relative Risk vs. Return Landscape
If you would invest 2,698 in Myovant Sciences on January 25, 2024 and sell it today you would earn a total of 0.00 from holding Myovant Sciences or generate 0.0% return on investment over 90 days. Myovant Sciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Myovant, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Myovant Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Myovant Sciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Myovant Sciences, and traders can use it to determine the average amount a Myovant Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MYOV |
Based on monthly moving average Myovant Sciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Myovant Sciences by adding Myovant Sciences to a well-diversified portfolio.
Myovant Sciences Fundamentals Growth
Myovant Stock prices reflect investors' perceptions of the future prospects and financial health of Myovant Sciences, and Myovant Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Myovant Stock performance.
| Return On Asset | -0.18 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.39) % | |||
| Current Valuation | 2.6 B | |||
| Shares Outstanding | 97.26 M | |||
| Price To Earning | (8.56) X | |||
| Price To Book | 70.01 X | |||
| Price To Sales | 7.80 X | |||
| Revenue | 230.97 M | |||
| EBITDA | (183.89 M) | |||
| Cash And Equivalents | 371.29 M | |||
| Cash Per Share | 3.84 X | |||
| Total Debt | 358.7 M | |||
| Debt To Equity | 138.60 % | |||
| Book Value Per Share | (5.75) X | |||
| Cash Flow From Operations | (268.56 M) | |||
| Earnings Per Share | (1.92) X | |||
| Total Asset | 520.01 M | |||
| Retained Earnings | (811.83 M) | |||
| Current Asset | 150.17 M | |||
| Current Liabilities | 27.14 M | |||
About Myovant Sciences Performance
To evaluate Myovant Sciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Myovant Sciences generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Myovant Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Myovant Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Myovant's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 579 people.Things to note about Myovant Sciences performance evaluation
Checking the ongoing alerts about Myovant Sciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Myovant Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Myovant Sciences is not yet fully synchronised with the market data | |
| Myovant Sciences has a very high chance of going through financial distress in the upcoming years | |
| Myovant Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 230.97 M. Net Loss for the year was (205.98 M) with profit before overhead, payroll, taxes, and interest of 72.02 M. | |
| Myovant Sciences currently holds about 371.29 M in cash with (268.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.84. | |
| Roughly 56.0% of the company shares are owned by institutional investors |
- Analyzing Myovant Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Myovant Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Myovant Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Myovant Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Myovant Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Myovant Sciences' stock. These opinions can provide insight into Myovant Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Myovant Stock
If you are still planning to invest in Myovant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myovant Sciences' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |